Immunostaining of Biocytin-filled and Processed Sections for Neurochemical Markers
December 31st, 2016
22.9K views
This protocol presents a method for the morphological recovery of neurons patched during electrophysiological recordings using biocytin filling and subsequent immunohistochemical postprocessing. We show that thick biocytin-filled sections that were stained and coverslipped can be restained with a second primary antibody days or months later.
Overview
This protocol presents an efficient method for recovering the morphology of neurons patched during electrophysiological recordings using biocytin filling and immunostaining. This technique allows for the identification of neurochemical markers in neurons, enhancing the understanding of their structural and functional diversity.
Key Study Components
Area of Science
- Neuroscience
- Electrophysiology
- Immunohistochemistry
Background
- Understanding neuronal morphology is crucial for studying brain networks.
- Data loss during morphological recovery can hinder research.
- This method addresses the challenge of recovering neuron morphology.
- Applicable to both thick and thin sections of neuronal samples.
Purpose of Study
- To present a reliable method for morphological recovery of neurons.
- To facilitate the identification of neurochemical identities in patched neurons.
- To minimize data loss in electrophysiological studies.
Methods Used
- Biocytin filling of patched neurons.
- Immunostaining techniques for morphological recovery.
- Sequential processing to allow for re-staining with specific antibodies.
- Application to both thick and thin sections of previously stained samples.
Main Results
- Successful morphological recovery of neurons using biocytin.
- Ability to re-stain thick sections days or months later.
- Enhanced identification of neurochemical markers in neurons.
- Reduction of data loss in neuronal studies.
Conclusions
- This method is effective for studying neuronal structure and function.
- It provides a valuable tool for researchers in neuroscience.
- Facilitates a better understanding of neuronal diversity in brain networks.
Frequently Asked Questions
What is the main advantage of this protocol?
The main advantage is the ability to recover neuron morphology without data loss, allowing for subsequent neurochemical analysis.
Can this method be applied to thin sections?
Yes, the method is applicable to both thick and thin sections of neuronal samples.
How long can sections be re-stained after initial processing?
Sections can be re-stained days or months after the initial processing.
What is biocytin used for in this protocol?
Biocytin is used for filling patched neurons to facilitate morphological recovery.
Why is understanding neuronal morphology important?
Understanding neuronal morphology is crucial for studying their roles in brain networks and overall function.
What types of antibodies can be used for re-staining?
Specific primary antibodies can be used for re-staining to determine neurochemical identity.
Executive Industry Relevance
In neuroscience drug discovery, linking electrophysiological phenotypes to molecular identities is critical for target validation and mechanistic de-risking. This protocol enables recovery of neuronal morphology prior to neurochemical profiling, reducing data loss and guiding efficient marker selection in patch-clamp workflows. It supports predictive confidence in target engagement studies by ensuring structural and chemical data are co-registered from the same recorded cell.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by correlating firing patterns with morphological recovery before neurochemical screening.
- Operational Value: Prevents loss of valuable electrophysiological data due to failed morphological recovery in thick tissue sections.
- Predictive Value: Supports target triage by allowing researchers to prioritize neurochemical markers based on confirmed cellular morphology.
Screening & Assay Development
- Scientific Value: Prepares validated neuronal structures for downstream immunostaining assays, ensuring assay readiness for neurochemical phenotyping.
- Operational Value: Standardizes recovery workflows, improving reproducibility across thick and thin sections for scalable screening campaigns.
- Assay Readiness: Enables reliable compound evaluation by preserving tissue integrity for sequential antibody staining.
Translational & Preclinical Research
- Translational Continuity: Maintains link between electrophysiological function and neurochemical identity from discovery through preclinical validation.
- Mechanistic De-risking: Reduces ambiguity in target characterization by confirming co-localization of biocytin-filled morphology with specific receptor expression.
- Risk-Adjusted Advancement: Informs go/no-go decisions by providing structural and chemical validation from the same neuronal sample.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from electrophysiological recording to lead identification, supporting hypothesis testing and biological de-risking before compound screening.
- Discovery Biology: Supports hypothesis testing by enabling recovery of dendritic and axonal morphology to clarify neuronal circuit targeting.
- Screening: Ensures assay readiness through standardized fixation, blocking, and staining steps that preserve tissue for re-staining.
- Analytics: Generates quantitative co-localization readouts (e.g., biocytin with CB1R or CCK) that help teams compare neurochemical phenotypes across conditions.
- Translational Research: Connects morphological recovery to preclinical continuity by preserving axonal and dendritic processes for biomarker alignment.
- Enterprise Reuse: Establishes a reusable capability for serial immunostaining, allowing multiple antibody probes to be applied to the same recovered morphology over time.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing mechanistic ambiguity in neuronal classification.
- Operational Value: Enhances standardization and reproducibility of morphological recovery across variable section thicknesses.
- Strategic Value: Improves capital efficiency by minimizing repeat electrophysiology runs due to data loss.
- Portfolio Impact: Enables risk-adjusted prioritization of neurochemical targets based on morphologically validated candidates.
Implementation Considerations
- Requires expertise in electrophysiology and microsurgical technique to re-seal the soma during pipette withdrawal.
- Depends on reliable perfusion and fixation infrastructure (e.g., 4% PFA, PBS washes) for antigen preservation.
- Necessitates standardized blocking and antibody incubation protocols to minimize background in sequential staining.
- Involves careful handling during coverslip removal and section recovery to preserve dendritic and axonal processes.
- Limited by the need for adequate dye transport time post-detachment to ensure complete morphological labeling.
Biopharma FAQs
Why is morphological recovery necessary before neurochemical staining in patch-clamp studies?
Recovering morphology first prevents data loss from failed resealing in thick sections and guides efficient selection of neurochemical markers to test based on structural identity.
How does re-sealing the soma during pipette withdrawal support reliable biocytin filling?
Re-sealing establishes an outside-out patch, allowing biocytin to diffuse into distal dendritic and axonal processes without leakage, ensuring complete morphology recovery.
What enables sections to be re-stained days after initial immunostaining?
Sections fixed in PFA, washed in PBS, and mounted with sealed coverslips can be safely unmounted, washed, and re-incubated with new antibodies without compromising prior signals.
Why is it important to validate neurochemical markers using the same cell with recovered morphology?
Co-localizing biocytin-filled morphology with specific antibody labeling (e.g., CB1R or CCK) confirms neurochemical identity in the recorded neuron, increasing target confidence.
What procedural steps ensure the prior immunostaining signal remains intact during re-staining?
Removing the coverslip, washing sections in PBS, and incubating with new primary and secondary antibodies preserves earlier fluorescence while enabling detection of additional neurochemical markers.
Chapters in this video
0:05
Title
1:19
Biocytin-filling during Electrophysiology
3:31
Staining of the First Primary Antibody and Biocytin
4:58
Staining of the Second Primary Antibody
6:32
Results: Successful CCK Staining 1 Week Following the Recovery of Biocytin Staining and CB1R Labeling
7:56
Conclusion
